Skip to main content
Top
Published in: Abdominal Radiology 3/2019

01-03-2019

Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient

Authors: Dina Attia, Thomas Rodt, Steffen Marquardt, Jan Hinrichs, Bernhard C. Meyer, Michael Gebel, Frank Wacker, Michael P. Manns, Andrej Potthoff

Published in: Abdominal Radiology | Issue 3/2019

Login to get access

Abstract

Background

Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure used to treat portal hypertension complications. Our aim was to evaluate liver and spleen stiffness measurement (LSM and SSM, respectively) changes using acoustic radiation force impulse imaging (ARFI) in comparison to Child–Pugh scores for predicting hepatic venous pressure gradient (HVPG) decreases after TIPS implantation.

Methods

This prospective study included 31 consecutive clinically significant portal hypertension patients with TIPS indication. All patients received LSM and SSM before TIPS, at baseline, 2 days (follow-up 1) and 6 weeks (follow-up 2) post-implantation. HVPG was performed during the TIPS procedure.

Results

The mean decrease in HVPG after TIPS was 63%. LSM and SSM decreased significantly between baseline and follow-up 2 (p < 0.001 and p < 0.001, respectively). At baseline, follow-up 1 and follow-up 2, significant correlations were detected between mean SSM and mean HVPG (p = 0.026; p = 0.018; p = 0.002, respectively). HVPG decreased to ≤ 10 mmHg in 61% of patients for which LSM, SSM, and Child–Pugh score were predictors (p = 0.033, p = 0.002 and p = 0.030, respectively). The area under the curve (AUC) for LSM, SSM, and Child–Pugh was 0.88, 0.90, and 0.84, respectively, with close sensitivity and specificity. SSM had the highest diagnostic accuracy for predicting an HVPG decrease to ≤ 10 mmHg in comparison to LSM and Child–Pugh score.

Conclusion

Spleen stiffness is superior to liver stiffness and Child–Pugh score as a non-invasive surveillance tool for evaluating patients with clinically significant portal hypertension (HVPG ≥ 10 mmHg) prior to TIPS.
Literature
1.
go back to reference D’Amico G, et al. (2006) Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131(5):1611–1624CrossRefPubMed D’Amico G, et al. (2006) Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131(5):1611–1624CrossRefPubMed
3.
go back to reference Testino G, et al. (2003) Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 50(54):1753–1755PubMed Testino G, et al. (2003) Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 50(54):1753–1755PubMed
5.
go back to reference de Franchis R, Baveno VIF (2015) Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 63(3):743–752CrossRef de Franchis R, Baveno VIF (2015) Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 63(3):743–752CrossRef
6.
go back to reference Pateria P, et al. (2017) Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. J Med Imaging Radiat Oncol 61(4):441–447CrossRefPubMed Pateria P, et al. (2017) Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. J Med Imaging Radiat Oncol 61(4):441–447CrossRefPubMed
7.
go back to reference Thabut D, et al. (2010) Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. J Hepatol 53(6):1029–1034CrossRefPubMed Thabut D, et al. (2010) Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. J Hepatol 53(6):1029–1034CrossRefPubMed
8.
go back to reference Cholongitas E, et al. (2005) Systematic review: The model for end-stage liver disease–should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22(11–12):1079–1089CrossRefPubMed Cholongitas E, et al. (2005) Systematic review: The model for end-stage liver disease–should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22(11–12):1079–1089CrossRefPubMed
9.
go back to reference Durand F, Valla D (2005) Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 42:S100–S107CrossRefPubMed Durand F, Valla D (2005) Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 42:S100–S107CrossRefPubMed
10.
go back to reference Gaba RC, et al. (2013) Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 24(3):411–420CrossRefPubMed Gaba RC, et al. (2013) Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 24(3):411–420CrossRefPubMed
11.
go back to reference Zhou C, et al. (2015) Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. Int J Clin Exp Med 8(8):13464–13472PubMedPubMedCentral Zhou C, et al. (2015) Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. Int J Clin Exp Med 8(8):13464–13472PubMedPubMedCentral
12.
go back to reference Trotter JF, Suhocki PV, Rockey DC (1998) Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. Am J Gastroenterol 93(10):1891–1894CrossRefPubMed Trotter JF, Suhocki PV, Rockey DC (1998) Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. Am J Gastroenterol 93(10):1891–1894CrossRefPubMed
13.
go back to reference Montgomery A, et al. (2005) MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 28(3):307–312CrossRefPubMed Montgomery A, et al. (2005) MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 28(3):307–312CrossRefPubMed
14.
go back to reference Mandorfer M, et al. (2016) Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol 65(4):692–699CrossRefPubMed Mandorfer M, et al. (2016) Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol 65(4):692–699CrossRefPubMed
15.
go back to reference Berzigotti A (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67(2):399–411CrossRefPubMed Berzigotti A (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67(2):399–411CrossRefPubMed
16.
go back to reference Attia D, et al. (2015) Evaluation of liver and spleen stiffness with acoustic radiation force impulse quantification elastography for diagnosing clinically significant portal hypertension. Ultraschall Med 36(6):603–610CrossRefPubMed Attia D, et al. (2015) Evaluation of liver and spleen stiffness with acoustic radiation force impulse quantification elastography for diagnosing clinically significant portal hypertension. Ultraschall Med 36(6):603–610CrossRefPubMed
17.
go back to reference Jansen C, et al. (2017) Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology 67:1472–1484CrossRef Jansen C, et al. (2017) Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology 67:1472–1484CrossRef
18.
go back to reference Buechter M, et al. (2018) Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis 50(1):54–60CrossRefPubMed Buechter M, et al. (2018) Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis 50(1):54–60CrossRefPubMed
19.
go back to reference De Santis A, et al. (2018) Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 33(3):704–709CrossRefPubMed De Santis A, et al. (2018) Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 33(3):704–709CrossRefPubMed
20.
go back to reference Gao J, et al. (2016) Shear wave elastography of the spleen for monitoring transjugular intrahepatic portosystemic shunt function: a pilot study. J Ultrasound Med 35(5):951–958CrossRefPubMed Gao J, et al. (2016) Shear wave elastography of the spleen for monitoring transjugular intrahepatic portosystemic shunt function: a pilot study. J Ultrasound Med 35(5):951–958CrossRefPubMed
21.
go back to reference Berzigotti A, et al. (2012) Ultrasound in portal hypertension–part 2–and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med 33(1):8–32CrossRefPubMed Berzigotti A, et al. (2012) Ultrasound in portal hypertension–part 2–and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med 33(1):8–32CrossRefPubMed
22.
go back to reference Feldstein VA, Patel MD, LaBerge JM (1996) Transjugular intrahepatic portosystemic shunts: accuracy of Doppler US in determination of patency and detection of stenoses. Radiology 201(1):141–147CrossRefPubMed Feldstein VA, Patel MD, LaBerge JM (1996) Transjugular intrahepatic portosystemic shunts: accuracy of Doppler US in determination of patency and detection of stenoses. Radiology 201(1):141–147CrossRefPubMed
23.
go back to reference Kanterman RY, et al. (1997) Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction. AJR Am J Roentgenol 168(2):467–472CrossRefPubMed Kanterman RY, et al. (1997) Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction. AJR Am J Roentgenol 168(2):467–472CrossRefPubMed
24.
go back to reference Foshager MC, et al. (1994) Color Doppler sonography of transjugular intrahepatic portosystemic shunts (TIPS). AJR Am J Roentgenol 163(1):105–111CrossRefPubMed Foshager MC, et al. (1994) Color Doppler sonography of transjugular intrahepatic portosystemic shunts (TIPS). AJR Am J Roentgenol 163(1):105–111CrossRefPubMed
25.
go back to reference Murphy TP, et al. (1998) Long-term follow-up after TIPS: use of Doppler velocity criteria for detecting elevation of the portosystemic gradient. J Vasc Interv Radiol 9(2):275–281CrossRefPubMed Murphy TP, et al. (1998) Long-term follow-up after TIPS: use of Doppler velocity criteria for detecting elevation of the portosystemic gradient. J Vasc Interv Radiol 9(2):275–281CrossRefPubMed
26.
go back to reference Haskal ZJ, et al. (1997) Sonography of transjugular intrahepatic portosystemic shunts: detection of elevated portosystemic gradients and loss of shunt function. J Vasc Interv Radiol 8(4):549–556CrossRefPubMed Haskal ZJ, et al. (1997) Sonography of transjugular intrahepatic portosystemic shunts: detection of elevated portosystemic gradients and loss of shunt function. J Vasc Interv Radiol 8(4):549–556CrossRefPubMed
27.
go back to reference Bamber J, et al. (2013) EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 34(2):169–184CrossRefPubMed Bamber J, et al. (2013) EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 34(2):169–184CrossRefPubMed
28.
go back to reference Nightingale K, et al. (2002) Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol 28(2):227–235CrossRefPubMed Nightingale K, et al. (2002) Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med Biol 28(2):227–235CrossRefPubMed
29.
go back to reference Potthoff A, et al. (2013) Influence of different frequencies and insertion depths on the diagnostic accuracy of liver elastography by acoustic radiation force impulse imaging (ARFI). Eur J Radiol 82(8):1207–1212CrossRefPubMed Potthoff A, et al. (2013) Influence of different frequencies and insertion depths on the diagnostic accuracy of liver elastography by acoustic radiation force impulse imaging (ARFI). Eur J Radiol 82(8):1207–1212CrossRefPubMed
30.
go back to reference Karlas T, et al. (2014) Assessment of spleen stiffness using acoustic radiation force impulse imaging (ARFI): definition of examination standards and impact of breathing maneuvers. Ultraschall Med 35(1):38–43CrossRefPubMed Karlas T, et al. (2014) Assessment of spleen stiffness using acoustic radiation force impulse imaging (ARFI): definition of examination standards and impact of breathing maneuvers. Ultraschall Med 35(1):38–43CrossRefPubMed
31.
go back to reference Lemoine M, et al. (2008) Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 28(9):1102–1110CrossRefPubMed Lemoine M, et al. (2008) Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 28(9):1102–1110CrossRefPubMed
32.
go back to reference Tzschatzsch H, et al. (2017) Time-harmonic elastography of the liver is sensitive to intrahepatic pressure gradient and liver decompression after transjugular intrahepatic portosystemic shunt (TIPS) implantation. Ultrasound Med Biol 43(3):595–600CrossRefPubMed Tzschatzsch H, et al. (2017) Time-harmonic elastography of the liver is sensitive to intrahepatic pressure gradient and liver decompression after transjugular intrahepatic portosystemic shunt (TIPS) implantation. Ultrasound Med Biol 43(3):595–600CrossRefPubMed
33.
go back to reference Procopet B, Berzigotti A (2017) Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) 5(2):79–89CrossRef Procopet B, Berzigotti A (2017) Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) 5(2):79–89CrossRef
34.
go back to reference Lindner F, et al. (2018) Predictive value of liver and spleen stiffness in advanced alcoholic cirrhosis with refractory ascites. Z Gastroenterol 56(6):561–568CrossRefPubMed Lindner F, et al. (2018) Predictive value of liver and spleen stiffness in advanced alcoholic cirrhosis with refractory ascites. Z Gastroenterol 56(6):561–568CrossRefPubMed
35.
36.
go back to reference Guturu P, Shah V (2009) New insights into the pathobiology of portal hypertension. Hepatol Res 39(10):1016–1019CrossRefPubMed Guturu P, Shah V (2009) New insights into the pathobiology of portal hypertension. Hepatol Res 39(10):1016–1019CrossRefPubMed
37.
go back to reference Yin M, et al. (2007) Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 58(2):346–353CrossRefPubMed Yin M, et al. (2007) Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 58(2):346–353CrossRefPubMed
38.
go back to reference Huwart L, et al. (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135(1):32–40CrossRefPubMed Huwart L, et al. (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135(1):32–40CrossRefPubMed
Metadata
Title
Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient
Authors
Dina Attia
Thomas Rodt
Steffen Marquardt
Jan Hinrichs
Bernhard C. Meyer
Michael Gebel
Frank Wacker
Michael P. Manns
Andrej Potthoff
Publication date
01-03-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1795-6

Other articles of this Issue 3/2019

Abdominal Radiology 3/2019 Go to the issue

Classics in Abdominal Radiology

The ovarian “string-of-pearls” sign

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine